Skip to main content

Table 2 Comparison of the incidence of gut dysbiosis in the patients from the three groups

From: The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota

 

Control group (n = 64)

Regular group (n = 67)

Double-dosage group (n = 65)

P-value

Within 7 days

 Incidence of gut dysbiosis (%)

21.88

14.93

6.15**

0.038*

Days 8–14

 Incidence of gut dysbiosis (%)

25.00

14.93

4.62**

0.005**

  1. * P < 0.05, **P < 0.01 compared to Control group